European Journal of Preventive Cardiology
Papers 4,805
1 page of 481 pages (4,805 results)
#1Vasiliki Tsampasian (UEA: University of East Anglia)H-Index: 1
#2Hussein Elghazaly (Imperial College London)H-Index: 3
Last. Vassilios S. Vassiliou (UEA: University of East Anglia)H-Index: 16
view all 9 authors...
#1Joep Perk (LNU: Linnaeus University)H-Index: 29
#1Gustavo dos Santos Ribeiro (UFCSPA: Universidade Federal de Ciências da Saúde de Porto Alegre)H-Index: 3
#2Camila Cargnin (UFCSPA: Universidade Federal de Ciências da Saúde de Porto Alegre)H-Index: 1
Last. Marlus Karsten (UDESC: Universidade do Estado de Santa Catarina)H-Index: 11
view all 6 authors...
#1Lotte M. de Boer (UvA: University of Amsterdam)H-Index: 1
#2Anna O J Oorthuys (UvA: University of Amsterdam)
Last. Barbara A. Hutten (UvA: University of Amsterdam)H-Index: 41
view all 8 authors...
AIMS Lipoprotein(a) [Lp(a)] is a causal and independent risk factor for cardiovascular disease (CVD). People with elevated Lp(a) are often prescribed statins as they also often show elevated low-density lipoprotein cholesterol (LDL-C) levels. While statins are well-established in lowering LDL-C, their effect on Lp(a) remains unclear. We evaluated the effect of statins compared to placebo on Lp(a) and the effects of different types and intensities of statin therapy on Lp(a). METHODS AND RESULTS W...
#1Francesco BiancoH-Index: 26
#1Chang Hoon Lee (SNUH: Seoul National University Hospital)H-Index: 29
#2Kyungdo Han (SSU: Soongsil University)H-Index: 37
Last. Min-Sun Kwak (SNUH: Seoul National University Hospital)H-Index: 1
view all 4 authors...
AIMS Continuing physical activity (PA) and maintaining body weight are tightly intertwined; however, no study investigated whether these two factors have interactions in terms of the mortality. The aim of this study is to elucidate whether continuing regular PA and maintaining body weight have interactions in terms of all-cause mortality risk. METHODS AND RESULTS Participants with health screening from both 2009 and 2011 without underlying cancer or cardiovascular disease were included. Physical...
#1Nan Zhang (TMU: Tianjin Medical University)H-Index: 3
#2Yueying Wang (TMU: Tianjin Medical University)H-Index: 4
Last. Tong Liu (TMU: Tianjin Medical University)H-Index: 32
view all 9 authors...
AIMS To examine the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on cardiac remodelling in patients with type 2 diabetes mellitus (T2DM) and/or heart failure (HF), and to explore the subsets of patients who may have greater benefit from SGLT2i therapy. METHODS AND RESULTS Four electronic databases were searched for randomized controlled trials (RCTs) that evaluated the effects of SGLT2i on parameters reflecting cardiac remodelling in patients with T2DM and/or HF. Standardized me...
#1Pedro Marques-Vidal (UNIL: University of Lausanne)H-Index: 61
#1Benjamin J R Buckley (University of Liverpool)H-Index: 4
#2Iris A de Koning (Radboud University Nijmegen)
Last. Dick H. J. Thijssen (LJMU: Liverpool John Moores University)H-Index: 50
view all 8 authors...
Aims null Accumulating evidence questions the clinical value of percutaneous coronary intervention (PCI) for patients with chronic coronary syndrome (CCS). We therefore compare the impact of exercise-based cardiac rehabilitation (CR) vs. PCI in patients with CCS on 18-month mortality and morbidity, and evaluate the effects of combining PCI with exercise-based CR. null Methods and results null A retrospective cohort study was conducted in March 2021. An online, real-world dataset of CCS patients ...
Top fields of study
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.